West Breaks Ground on Facility in Ireland
PTSM: Pharmaceutical Technology Sourcing and Management
West Pharmaceutical began construction on its component manufacturing facility located in Waterford, Ireland.
West Pharmaceutical announced on June 16, 2015 that it broke ground on its Waterford, Ireland facility. The new pharmaceutical component manufacturing facility will focus on manufacturing “packaging components for insulin injector cartridges and other high-value packaging components for injectable drugs,” according to a press release.
"West's presence in Ireland is of great importance to us for meeting customer demand for high-quality packaging components. Packaging systems play an important role in ensuring the purity, long-term stability, and efficacy of injectable drug products. The advanced components that will be produced at our state-of-the-art Waterford plant will help our pharmaceutical and biotechnology customers deliver their products to patients," said Eric Green, CEO at West, in a press release.
The 95,000-square-foot-facility is expected to be opened in late 2018, and will employ approximately 150 engineers, production personnel, and other positions.
Source: West Pharmaceutical
FDA Approves First Treatment for Rare Lipid Storage Disease Cerebrotendinous Xanthomatosis
February 24th 2025Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
